Outcomes of Surgical Treatment of Skin Cancer at Surgical Oncology Unit of Donka, Conakry University Hospital

DOI: 10.4236/jct.2017.812093   PDF   HTML   XML   526 Downloads   1,123 Views   Citations


Aim: The main aim of this study was to evaluate outcomes after surgical treatment of skin cancer. Methods: This retrospective cohort study concerned 46 patients who presented 43 skin cancers lesions surgically treated at surgical oncology unit, Conakry University Hospital. There were 29 (61.7%) squamous cell carcinoma, 12 (25.5%) melanoma, 4 (8.5%) sarcomas and 1 (2.1%) porocarcinoma. Surgical indications and prognosis factors were analyzed. Results: Surgical treatment included simple excision in 2 cases (3.8%), wide excision in 38 cases (71.7%) and amputation/disarticulation in 13 cases (24.5%). Inguinal lymph node dissection was performed in 16 patients (34.3%). Postoperative complications were wound suppuration (5 cases), lower limb lymphedema (4 cases), seroma (2 cases) and skin flap necrosis (1 case). Surgical margins were free in 28 (60.9%) patients, infiltrated in 3 patients (6.5%) and unspecified in 15 patients (32.6%). The median follow-up after surgery was 29 months. During the follow-up, 13 patients (28.3%) had a relapse. The relapse was influenced by surgical margins (p = 0.012) and iterative resection (p = 0.04). Overall survival was 65.2%. Factors related to survival in univariate analysis were: iterative resection (p = 0.008), fungated tumor (p = 0.037), the status of surgical margins (p = 0.002) and the occurrence of relapse (p = 0.0000). In multivariate analysis, the status of surgical margins was the only independent prognostic factor. Conclusion: The prognosis after surgical treatment of cutaneous cancers depends on the resection margins.

Share and Cite:

Traore, B. and Lamah, L. (2017) Outcomes of Surgical Treatment of Skin Cancer at Surgical Oncology Unit of Donka, Conakry University Hospital. Journal of Cancer Therapy, 8, 1086-1094. doi: 10.4236/jct.2017.812093.

Conflicts of Interest

The authors declare no conflicts of interest.


[1] Traore, B., Keita, M., Conde, M., et al. (2016) Anatomo-Clinical Characteristics of Skin Cancers at the Surgical Oncology Unit of the Conakry University Hospital. Rev. CAMES SANTE, 4, 79-82
[2] Clairwood, M., Ricketts, J., Grant-Kels, J. and Gonsalves, L. (2014) Melanoma in Skin of Color in Connecticut: An Analysis of Melanoma Incidence and Stage at Diagnosis in Non-Hispanic Blacks, Non-Hispanic Whites, and Hispanics. International Journal of Dermatology, 53, 425-33.
[3] Eisemann, N., Waldmann, A., Geller, A.C., et al. (2014) Non-Melanoma Skin Cancer Incidence and Impact of Skin Cancer Screening on Incidence. Journal of Investigative Dermatology, 134, 43-50.
[4] Asuquo, M.E. and Ebughe, G. (2012) Major Dermatological Malignancies Encountered in the University of Calabar Teaching Hospital, Calabar, Southern Nigeria. International Journal of Dermatology, 51, 36-40.
[5] Forae, G.D. and Olu-Eddo, A.N. (2013) Malignant Skin Tumors in Benin City, South-South, Nigeria. Oman Medical Journal, 28, 311-315.
[6] Oseni, G.O., Olaitan, P.B., Komolafe, A.O., et al. (2015) Malignant Skin Lesions in Oshogbo, Nigeria. Pan African Medical Journal, 20, 253.
[7] Deo, S.V., Hazarika, S., Shukla, N.K., et al. (2005) Surgical Management of Skin Cancers: Experience from a Regional Cancer Centre on North India. Indian Journal of Cancer, 42, 145-150.
[8] Sobin, L.H., Gospodarowicz, M.K. and Wittekind, C. International Union against Cancer. TNM Classification of Malignant Tumours. 7th ed, 2009, West Sussex, Chichester, UK, 2010, Wiley-Blackwell, Hoboken, NJ.
[9] Gualdi, G., Monari, P., Apalla, Z. and Lallas, A. (2015) Surgical Treatment of Basal Cell Carcinoma and Squamous Cell Carcinoma. Giornale Italiano Di Dermatologia E Venereologia, 150, 435-447.
[10] Parsons, C.M., Pimiento, J.M., Cheong, D., et al. (2012) The Role of Radical Amputations for Extremity Tumors: A Single Institution Experience and Review of the Literature. Journal of Surgical Oncology, 105, 149-155.
[11] Pisoh, T.C., Ngowe Ngowe, M., Watcoun-Nchinda, E.P., et al. (2011) Surgical Treatment of Lower Limb Malignant Melanoma IN Yaounde Cameroon. Health Sciences and Disease, 12.
[12] Kandel, R., Coakley, N., Werier, J., et al. (2013) Surgical Margins and Handling of Soft-Tissue Sarcoma in Extremities: A Clinical Practice Guideline. Current Oncology, 20, e247-e254.
[13] Lane, J.E. and Kent, D.E. (2005) Surgical Margins in the Treatment of Nonmelanoma Skin Cancer and Mohs Micrographic Surgery. Journal of Surgical Education, 62, 518-526.
[14] Ad Hoc Task Force, Connolly, S.M., Baker, D.R., Coldiron, B.M. and AAD/ACMS/ASDSA/ASMS (2012) Appropriate Use Criteria for Mohs Micrographic Surgery: A Report of the American Academy of Dermatology, American College of Mohs Surgery, American Society for Dermatologic Surgery Association, and the American Society for Mohs Surgery. Journal of the American Academy of Dermatology, 67, 531-550.
[15] Ul-Mulk, J. and Holmich, L.R. (2012) Lymph Node Dissection in Patients with Malignant Melanoma Is Associated with High Risk of Morbidity. Danish Medical Journal, 59, A4441.
[16] Matthey-Giè, M.-L., Boubaker, A., Letovanec, I., et al. (2013) Sentinel Lymph Node Biopsy in Nonmelanoma Skin Cancer Patients. Journal of Skin Cancer, 2013, Article ID: 267474.
[17] Opara, K.O. and Jiburum, B.C. (2010) Skin Cancers in Albinos in a Teaching Hospital in Eastern Nigeria - Presentation and Challenges of Care. World Journal of Surgical Oncology, 8, 73.

comments powered by Disqus

Copyright © 2020 by authors and Scientific Research Publishing Inc.

Creative Commons License

This work and the related PDF file are licensed under a Creative Commons Attribution 4.0 International License.